CP
CNS Pharmaceuticals, Inc.
SEC filingPharmaceuticals · Houston, TX
Amount raised$22.5Msold at filing
Total offering$22.5M
Investors in the raise13count reported to the SEC
FiledMay 19, 2026first sale May 4, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Rami LevinExecutive Officer, Director
Amy MaheryDirector
Jeffry KeyesDirector
Steve O'LoughlinExecutive Officer
Faith CharlesDirector
Michal FisherDirector
Bettina CockroftDirector
Executive officers, directors and promoters as listed on the Form D.